<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00623584</url>
  </required_header>
  <id_info>
    <org_study_id>SKC001SFM08</org_study_id>
    <nct_id>NCT00623584</nct_id>
  </id_info>
  <brief_title>Comparison of Corneal Grafts Cultured in Serum-free Versus Corneal Grafts Cultured in Serum Supplemented Culture Media</brief_title>
  <acronym>SFM</acronym>
  <official_title>In Vitro and Clinical Comparison of Corneal Grafts Cultured in Serum Free Medium or Standard Serum Supplemented Medium in Patients With Degeneration of the Corneal Endothelium</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klinikum Chemnitz gGmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>KKS Netzwerk</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Klinikum Chemnitz gGmbH</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this clinical trial is to compare the quality of corneal grafts cultured in a
      serum-free culture medium with a defined composition versus corneal grafts cultured in a
      standard serum supplemented culture medium transplanted in patients with decompensated
      corneal dystrophy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this clinical trial is to test the equivalence of the quality of the
      corneal grafts cultured under serum free conditions to corneal grafts cultured in the Minimal
      Essential Medium supplemented with 2% fetal calf serum, based on a parallel comparison of the
      endothelial cell density of paired corneal grafts deriving from single donors at different
      time points before and after the grafting procedure. In addition, the safety of the clinical
      use of corneal grafts cultured in both media will be determined. The graft survival rate
      during the follow-up period will be quantified in regard to immune mediated graft rejection
      and non-immune mediated graft failure, as well as the incidence of corneal edema, corneal
      opacities and corneal neovascularisation.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>April 2011</start_date>
  <completion_date type="Anticipated">October 2012</completion_date>
  <primary_completion_date type="Anticipated">April 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary outcome is the endothelial cell density of the corneal grafts prior to and after the transplantation procedure</measure>
    <time_frame>The measurment will be performed prior to and 1, 4, 12, 24, 36, 48 and 60 months after the transplantation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary study outcomes are immune mediated graft rejection, non-immune mediated graft failure, as well as the incidence of corneal edema, corneal opacities and corneal neovascularisation.</measure>
    <time_frame>1,4,12, 24, 36, 48 and 60 month after the transplantation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Fuch's Endothelial Dystrophy</condition>
  <condition>Pseudophakic Bullous Keratopathy</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this arm randomly receive a corneal graft cultured in a serum free culture medium</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this arm randomly receive a corneal graft cultured in a serum supplemented culture medium</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Corneal transplantation</intervention_name>
    <description>Full thickness penetrating keratoplasty</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Corneal transplantation</intervention_name>
    <description>Full thickness penetrating keratoplasty</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female patients between 50 and 85 years of age

          -  Clinically proven Fuchs corneal dystrophy or secondary decompensation the corneal
             endothelium (e. g. after surgical intervention in the anterior segment of the eye)

          -  Patient informed consent

        Exclusion Criteria:

          -  Previous penetrating keratoplasty

          -  Corneal neovascularisation

          -  Pathologic changes in the anterior segment of the eye (anterior / posterior synechiae,
             uveitis)

          -  Glaucoma

          -  Aphakia

          -  Infectious diseases of the cornea

          -  Neurodermitis

          -  Participation of the patient in another clinical trial within the last four weeks that
             precede the recruitment

          -  The patient is unlikely to comply with the requirements of the protocol

          -  Previous or current abuse of medications, narcotics or alcohol

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katrin Engelmann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinikum Chemnitz GmbH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Katrin Engelmann, MD</last_name>
    <phone>+ 49 371 333 33230</phone>
    <email>k.engelmann@skc.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Simo Murovski, MD</last_name>
    <phone>+ 49 371 6000020</phone>
    <email>s.murovski@poliklinik-chemnitz.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitäts Augenklinik</name>
      <address>
        <city>Halle (Saale)</city>
        <state>Sachsen-Anhalt</state>
        <zip>06120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gernot Duncker, MD</last_name>
      <phone>+49 345 557 1878</phone>
      <email>gernot.duncker@medizin.uni-halle.de</email>
    </contact>
    <contact_backup>
      <last_name>Timm Bredehorn, MD</last_name>
      <phone>+ 49 345 557 1575</phone>
      <email>timm.bredehorn@dso.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Augenklinik, Klinikum Chemnitz gGmbH</name>
      <address>
        <city>Chemnitz</city>
        <state>Saxony</state>
        <zip>091116</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Katrin Engelmann, MD</last_name>
      <phone>+ 49 371 333 33230</phone>
      <email>k.engelmann@skc.de</email>
    </contact>
    <contact_backup>
      <last_name>Simo Murovski, MD</last_name>
      <phone>+ 49 371 6000020</phone>
      <email>s.murovski@poliklinik-chemnitz.de</email>
    </contact_backup>
    <investigator>
      <last_name>Katrin Engelmann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Hempel B, Bednarz J, Engelmann K. Use of a serum-free medium for long-term storage of human corneas. Influence on endothelial cell density and corneal metabolism. Graefes Arch Clin Exp Ophthalmol. 2001 Oct;239(10):801-5.</citation>
    <PMID>11760044</PMID>
  </reference>
  <reference>
    <citation>Bednarz J, Doubilei V, Wollnik PC, Engelmann K. Effect of three different media on serum free culture of donor corneas and isolated human corneal endothelial cells. Br J Ophthalmol. 2001 Dec;85(12):1416-20.</citation>
    <PMID>11734511</PMID>
  </reference>
  <reference>
    <citation>Uphoff J, Bednarz J, Engelmann K. [Follow-up of endothelial cell density after perforating keratoplasty. Effect of donor and recipient-related factors]. Ophthalmologe. 2001 Jun;98(6):550-4. German.</citation>
    <PMID>11450479</PMID>
  </reference>
  <reference>
    <citation>Møller-Pedersen T, Hartmann U, Møller HJ, Ehlers N, Engelmann K. Evaluation of potential organ culture media for eye banking using human donor corneas. Br J Ophthalmol. 2001 Sep;85(9):1075-9.</citation>
    <PMID>11520760</PMID>
  </reference>
  <reference>
    <citation>Møller-Pedersen T, Hartmann U, Ehlers N, Engelmann K. Evaluation of potential organ culture media for eye banking using a human corneal endothelial cell growth assay. Graefes Arch Clin Exp Ophthalmol. 2001 Oct;239(10):778-82.</citation>
    <PMID>11760040</PMID>
  </reference>
  <verification_date>December 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2008</study_first_submitted>
  <study_first_submitted_qc>February 25, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 26, 2008</study_first_posted>
  <last_update_submitted>December 7, 2010</last_update_submitted>
  <last_update_submitted_qc>December 7, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 8, 2010</last_update_posted>
  <responsible_party>
    <name_title>Prof. Dr. med. Katrin Engelmann</name_title>
    <organization>Eye Clinic Chemnitz</organization>
  </responsible_party>
  <keyword>penetrating keratoplasty</keyword>
  <keyword>corneal transplantation</keyword>
  <keyword>corneal grafting</keyword>
  <keyword>corneal grafts</keyword>
  <keyword>culture media</keyword>
  <keyword>corneal culturing</keyword>
  <keyword>in vitro culturing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fuchs' Endothelial Dystrophy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

